Jason Hope Collaborates With Dr. Aubrey de Grey
Jason hope is a prominent futurist in Arizona. Jason hope has been advocated for many technological developments as an investor. He has so far been incredibly successful in finding technologies that find success in the market and as such is known in the United States as one of the leading futurists in the country. Recently he has taken an interest in rejuvenation biotechnologies. This is an area of technological development that is aiming at extending a person’s life and enhancing their overall quality of life. In 2010 Jason gave the SENS research foundation $500,000 to support their research. Over the last eight years, he has continued to give to the foundation and has now donated over $1 million to support their research.
The research foundation is focused on developing strategies for negligible senescence. This is the scientific term describing stopping the aging process. There are animals which naturally display negligible senescence such as tortoises and lobsters. These animals show little to no decline in their physical capabilities due to aging. This is not the same for humans. As a human ages, their body breaks down. This causes a rise in disease over the life of a human being.The research foundation has devoted itself to gaining an understanding of the aging process and developing treatment protocols to stop it in its tracks. Jason hope chose this organization because the approach that it takes is unique. Conventional medicine treats symptoms as they appear. This research foundation, on the other hand, is developing treatment protocols that prevent the diseases from ever happening in the first place.
One of the most significant advancements that has occurred at the research foundation is related to advanced glycation end products. These are the metabolic byproducts that accumulate within the human body as we age. Over time as the levels of these metabolic byproducts increase our skin and arteries becomes harder. The research foundation has developed a new compound which is capable of breaking down these metabolic byproducts. Jason has been working closely with the organization’s chief science officer Dr. Aubrey de Grey. The laboratories that Dr. Aubrey operates have focused on reversing the aging process. Together with Jason Dr. Aubrey has donated $10 million to the research foundation. It is there hope that the research foundation’s efforts will develop treatments for age-related diseases such as Alzheimer’s and Parkinson’s. They believe that it is possible to not only slow down aging but reversed the process altogether.